Although mainly poor treatment or survival outcomes associated with high PD-1/PD-L1 expression have been reported, a favorable prognostic value of this expression profile was reported in association with HPV-positive head-and-neck cancer patients and for some hematologic tumors [14, 15]. This evidence concerns the gene CD274 and head and neck cancer.